Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Current Opinion in Pharmacology|August 7, 2003
JNK: a new therapeutic target for diabetesBrydon L Bennett, Yoshitaka Satoh, Alan J LewisJournal of Hepatology|May 12, 2005
JNK mediates hepatic ischemia reperfusion injuryTetsuya Uehara, Brydon Bennett, Steve T Sakata, et al.Transplantation|May 24, 2007
Suppression of alloreactivity and allograft rejection by SP600125, a small molecule inhibitor of c-Jun N-terminal kinaseAkihiro Tabata, Masayuki Morikawa, Masahiro Miyajima, et al.International Journal of Molecular Medicine|February 9, 2006
Pro-inflammatory signaling by Jun-N-terminal kinase in inflammatory bowel diseaseKeiichi Mitsuyama, Asuka Suzuki, Nobuo Tomiyasu, et al.Molecular Cancer Therapeutics|December 20, 2014
A novel compound, NK150460, exhibits selective antitumor activity against breast cancer cell lines through activation of aryl hydrocarbon receptorKazuteru Fukasawa, Shigehide Kagaya, Sakiko Maruyama, et al.Journal of Medicinal Chemistry|April 21, 2017
A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and AiolosMary E Matyskiela, Weihong Zhang, Hon-Wah Man, et al.Journal of Medicinal Chemistry|December 13, 2021
Discovery of the c-Jun N-Terminal Kinase Inhibitor CC-90001Mark A Nagy, Robert Hilgraf, Deborah S Mortensen, et al.Bioorganic & Medicinal Chemistry Letters|January 17, 2012
Discovery of CC-930, an orally active anti-fibrotic JNK inhibitorVéronique Plantevin Krenitsky, Lisa Nadolny, Mercedes Delgado, et al.Bioorganic & Medicinal Chemistry Letters|January 10, 2012
Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injuryVéronique Plantevin Krenitsky, Mercedes Delgado, Lisa Nadolny, et al.Pageof 1